Oppenheimer & Co. Inc. Buys 1,801 Shares of Axon Enterprise, Inc $AXON

Oppenheimer & Co. Inc. boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 57.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 4,922 shares of the biotechnology company’s stock after buying an additional 1,801 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $2,759,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of AXON. Edgewood Management LLC purchased a new position in Axon Enterprise during the fourth quarter worth $846,516,000. Wellington Management Group LLP increased its position in Axon Enterprise by 326.9% during the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after acquiring an additional 1,179,038 shares during the last quarter. Norges Bank purchased a new stake in shares of Axon Enterprise in the fourth quarter valued at $515,764,000. Styrax Capital LP purchased a new stake in shares of Axon Enterprise in the first quarter valued at $84,938,000. Finally, Sands Capital Management LLC lifted its holdings in shares of Axon Enterprise by 11.6% in the 4th quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock worth $914,047,000 after acquiring an additional 167,095 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on AXON shares. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Barclays increased their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. The Goldman Sachs Group reissued a “buy” rating and issued a $715.00 price objective on shares of Axon Enterprise in a research note on Thursday, August 6th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $730.92.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 9,930 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $548.77, for a total value of $5,449,286.10. Following the completion of the sale, the chief executive officer directly owned 3,031,067 shares of the company’s stock, valued at $1,663,358,637.59. The trade was a 0.33% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Caitlin Elizabeth Kalinowski sold 564 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $478.97, for a total transaction of $270,139.08. Following the completion of the sale, the director directly owned 3,632 shares of the company’s stock, valued at approximately $1,739,619.04. This trade represents a 13.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 68,989 shares of company stock worth $36,016,932 over the last ninety days. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Stock Down 0.4%

NASDAQ:AXON opened at $612.83 on Friday. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $794.29. The company has a market cap of $49.78 billion, a price-to-earnings ratio of 254.29, a price-to-earnings-growth ratio of 12.56 and a beta of 1.39. The stock has a fifty day simple moving average of $526.06 and a 200-day simple moving average of $474.40. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The firm had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business’s revenue was up 35.3% on a year-over-year basis. During the same period in the previous year, the firm earned $2.12 earnings per share. Analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current year.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.